Zhangzhou Pientzehuang Pharmaceutical | 600436 - Umsatzkosten

Aktienkurs
150.70
Täglich Wechseln
-0.19 -0.13%
Monatlich
-4.41%
Jährlich
-26.49%
Q2 Prognose
147.47




Umsatzkosten Veränderung Datum
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Avita Medical AUD 3.3M 166K 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Jiangsu Hengrui CNY 1.17B 86.74M 2025-12
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Moderna USD 452M 245M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Sh Fosun Pharma CNY 5.57B 492.91M 2025-12
Viatris USD 2.56B 167.3M 2025-12
Wuxi Apptec CNY 6.26B 64.7M 2025-12
Xeris Pharmaceuticals USD 13.66M 49K 2025-12
Zz Pientze Pharmaceu CNY 1.34B 601.08M 2025-09